Laboratorios Farmaceuticos Rovi SA (Rovi), a subsidiary of Norbel Inversiones SL, is a pharmaceutical company that carries out the research, development, manufacturing, and marketing of prescription and hospital products. The company's product portfolio includes licensed prescription pharmaceuticals in the therapeutic areas of cardiovascular, osteoarticular, thrombosis, pneumology, gynecology, central nervous system (CNS), endocrinology, oncology, and urology; diagnostic imaging products include contrast agents and injection systems for imaging procedures such as computed tomography, X-rays, magnetic resonance imaging and ultrasound screening; products for the care and maintenance of venous and arterial catheters. It markets its products in Italy, the UK, Austria, Ireland, Hungary, Poland, Spain, Portugal and others. Rovi is headquartered in Madrid, Spain.
Headquarters
Spain
Address
C/ Julian Camarillo, 35, Madrid, 28037
Website
www.rovi.es
Telephone
34 913 756230
No of Employees
2,111
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
ROVI (MCE)
Revenue (2022)
$897.1M
1.4%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-14.7%
(2022 vs 2021)
Market Cap*
$4.6B
Net Profit Margin (2022)
XYZ
-15.9%
(2022 vs 2021)
* As of and is in US$
Laboratorios Farmaceuticos Rovi SA premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Prescription Medicines | Rovi |
| Hospital | Hibor |
| Diagnostic Imaging and Catheter Care Products | Osseor |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
Competitor Comparison
| Key Parameters | Laboratorios Farmaceuticos Rovi SA | Grifols SA | Almirall SA | Faes Farma SA | Laboratorios Richmond SACIF |
|---|---|---|---|---|---|
| Headquarters | Spain | Spain | Spain | Spain | Argentina |
| City | Madrid | Barcelona | Barcelona | Madrid | Buenos Aires |
| State/Province | Madrid | Barcelona | - | Madrid | Ciudad Autonoma De Buenos Aires |
| No. of Employees | 2,111 | 23,744 | 1,904 | 1,748 | - |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Juan Lopez-Belmonte Lopez | Director; Chief Executive Officer; President | Executive Board | - | - |
| Javier Lopez-Belmonte Encina | Vice President; Director | Executive Board | - | - |
| Ivan Lopez-Belmonte Encina | Director; Vice President | Executive Board | - | - |
| Gabriel Nunez Fernandez | Secretary | Senior Management | - | - |
| Ignacio Zarzalejos Toledano | Deputy Secretary | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward